Omeros (OMER) Inventory (2014 - 2026)

Omeros (OMER) reported Inventory of $183000.0 for Q1 2026, down 74.3% sequentially from $712000.0 in Q3 2021.

Omeros (OMER) Inventory (2014 - 2026) Analysis & Trends

Omeros (OMER) has 9 years of Inventory data on file, last reported at $183000.0 in Q1 2026.

For the quarter ending Q1 2026, Inventory changed N/A year-over-year to $183000.0; the trailing twelve-month figure through Mar 2026 stood at $183000.0 (changed N/A YoY), and the FY2020 full-year result was $1.4 million, up 18.13% from the prior year.
Inventory fell to $183000.0 in Q1 2026, from $712000.0 in the prior quarter.
In the past five years, Inventory ranged from a high of $183000.0 in Q1 2026 to a low of $183000.0 in Q1 2026.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	681.59 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	1.77 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	3.10 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	371.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Omeros	739.31 Mn	739.31 Mn	9.31 Mn	183,000.00

Historic Data

Download Data

Date	Value
Mar 31, 2026	183,000.00
Sep 30, 2021	712,000.00
Jun 30, 2021	978,000.00
Mar 31, 2021	1.19 Mn
Dec 31, 2020	1.36 Mn
Sep 30, 2020	1.54 Mn
Jun 30, 2020	1.89 Mn
Mar 31, 2020	1.21 Mn
Dec 31, 2019	1.15 Mn
Sep 30, 2019	1.17 Mn
Jun 30, 2019	1.19 Mn
Mar 31, 2019	736,000.00
Dec 31, 2018	88,000.00
Sep 30, 2018	214,000.00
Jun 30, 2018	235,000.00
Mar 31, 2018	247,000.00
Dec 31, 2017	443,000.00
Sep 30, 2017	822,000.00
Jun 30, 2017	905,000.00
Mar 31, 2017	960,000.00